Mar Vista Animal Medical Center

3850 Grand View Blvd.
Los Angeles, CA 90066



(original graphic by


The pancreas is a small light pink glandular organ nestled under the stomach and along side the duodenum (upper small intestine). The "endocrine" pancreas is the part of the pancreas that secretes hormones involved in blood sugar regulation, such as insulin and glucagon. The "exocrine" pancreas produces enzymes we use to digest our food. These two parts of the pancreas are not in separate areas but instead these two different types of pancreatic tissues are all mixed together throughout the entire pancreas.

The light pink tissue is an Islet of Langerhans (the insulin-secreting portion of the endocrine pancreas).
The darker pink tissue is the digestive enzyme secreting exocrine pancreas.
(Photocredit: Polarlys  via Wikimedia Commons)

The insulin-secreting cells are called “beta cells” and are bunched in groups called “Islets of Langerhans” which are scattered through out the pancreatic tissue. In some unfortunate individuals, the beta cells become tumorous and while the tumor itself can be very small, because it produces large amounts of insulin, its effects are very large. Insulin-secreting tumors are called, “insulinomas.”



Insulin is a hormone secreted to store sugar. Normally it is secreted in response to the carbohydrates in a meal; it allows the extra sugar to be removed from the bloodstream and stored as starch and fat thus keeping the blood sugar level within the normal range. The function of normal islets of Langerhans is tightly regulated by the body but if there is an insulin-secreting tumor, the tumor is not subject to this regulation. Insulin secretion runs wild in this situation and low blood sugar (“hypoglycemia”) becomes a problem.

The hypoglycemia in this situation is typically severe most commonly resulting in seizures. Other clinical features include: listlessness, twitching, trembling, apparently drunken or wobbly gait, and reduced mental awareness.



One of the first steps in evaluating any patient that is sick is a basic blood panel. Patients presented during a seizure are commonly screened for low blood sugar. The low blood sugar is typically recognized early in the diagnostic process though if the blood sugar has had time to recover (if the patient has eaten or depending what emergency medications have been given), the situation may be ambiguous. Sometimes the patient must return in a fasted state to get an accurate blood sugar assessment.

Assuming hypoglycemia is confirmed, the history and basic physical examination generally rule out some obvious potential causes. Some examples of fairly obvious potential causes of hypoglycemia include:

(original graphic by

  • Toy Breed Puppy Hypoglycemia
  • Diabetic patient possibly overdosing on insulin
  • Pregnant female in labor having a difficult delivery
  • Extreme exercise exertion as in “Hunting Dog Hypoglycemia”
  • Starvation
  • Over-whelming bacterial infection

Other not so obvious causes of hypoglycemia include liver disease, insulinoma, and hypoadrenocorticism (“Addison’s Disease”). The testing that is commonly needed beyond the basic panel would include: a resting cortisol level (a normal level largely rules out hypoadrenocortism), an ACTH Stimulation test (the definitive test for ruling out hypoadrenocorticism), an insulin level (which must be measured at the time the patient is hypoglycemic), and possibly a bile acids liver function test (if it is not clear if liver disease has been adequately ruled out by earlier findings).


What is Hypoadrenocorticism?

Hypoadrenocorticism is a deficiency in the production of cortisol (more commonly known as “cortisone”). Cortisol is produced by the adrenal gland and one of its functions is to raise blood sugar in anticipation of a fight or flight response. In more simple terms, if the body is anticipating exercise (such as fighting for one’s life or escaping a predator), blood sugar must be readily available for the muscles to burn. Cortisol is secreted to make that happen. (It also makes other metabolic adaptations happen as well but that is a story for another time.) Poor cortisol secretion can create episodes of hypoglycemia and since hypoadrenocorticism is easily treated once identified, it is very important to rule it out in a hypoglycemic patient.

For more information on this condition, click here.


The Insulin Level

To be meaningful in testing for insulinoma, the insulin level must be drawn when the patient’s blood sugar level is less than 60 mg/dl. This is because the insulin level is interpreted in light of the blood sugar level. In other words, an insulin level might be within the normal range for a normal patient but might be inappropriately high in a hypoglycemic patient.



Once one is confident that excessive insulin is being produced, the next step is ultrasound.
There are two reasons for this:

  • To locate the tumor if one is planning surgery
  • To obtain prognosis even if one is not planning surgery

Dr. Jon Perlis of DVMSound at our hospital performing ultrasound exam.
(original graphic by


Another reason to image the abdomen with ultrasound includes, searching for tumors that might cause hypoglycemia other than insulinoma. Most notoriously the hepatoma (also known as the hepatocellular carcinoma) and smooth muscle tumors (both benign and malignant and usually found in the spleen) also cause hypoglycemia. Other tumors potentially can consume enough blood sugar to create hypoglycemia and ultrasound would be an excellent way to find them if they are present.


Unfortunately, most insulinomas in dogs and cats are malignant but, despite this bad news, surgery is still very helpful in palliation and extending long-term life quality. Surgery removes the bulk of the tumor, if not all of it, which addresses the tumor's ability to drop blood sugar with many patients living normal lives for a year or more before the tumor significantly regrows (see below). Because insulinomas can be very small (sometimes too small to see during surgical exploration), ultrasound is helpful to evaluate the texture of the pancreatic tissue. In this way, even very small lesions can be identified. Further, with ultrasound, tumor spread to other organs can be evaluated thus helping to determine if it is worth pursuing surgery or if perhaps it is too late for this option and medication should be pursued instead.


With ultrasound, lesions in the pancreas as small as 7mm in diameter can be identified and, in one study, ultrasound was able to locate the pancreatic tumor in 75% of cases. If ultrasound fails to locate the tumor, more advanced imaging such as CT (CAT) scanning is likely to find it. With the tumor being so small, knowing its location will be important in planning surgery.



Surgical removal of the tumor is not a simple surgery. Manipulating the tumor can cause insulin surges which result in hypoglycemia during surgery; blood sugar levels must be tightly monitored both during and after surgery. Sugar-containing IV fluids are a must. Further, manipulation of the pancreas can create inflammation (“pancreatitis”) which is associated with pain and nausea. Some patients have been exposed to excess insulin so long that their normal beta cells require a prolonged period to recover and during this time the patient may require insulin injections just as a diabetic patient would.

This all sounds like a lot of risk for the treatment of a tumor with a 90% chance of malignancy however, 50% of dogs without evidence of tumor spread at the time of surgery have had normal blood sugars for a year after partial removal of the pancreas. This is an excellent statistic and is often well worth the surgery. Young dogs tend to have a poorer prognosis. Evidence of lymph node spread has not affected prognosis but the presence of tumor spread in the liver decreases survival time. In one study, dogs receiving partial pancreas removal had a medial remission time of 496 days and the dogs that went on to receive medical management after signs recurred had a median survival of 1316 days. Dogs with medical management alone had a median survival of 196 days.



Medical management is helpful for patients where surgery is not considered an option due to other risk factors, financial limitations, or the presence of a non-resectable tumor. Many months of symptom control can be achieved with diet, steroids (hormones related to cortisol which raise blood sugar), and an oral medication called diazoxide. Frequent small meals can be used to keep blood sugar in a reasonable range. If hypoglycemic disorientation occurs, it can generally be stopped with sugar supplements (Nutrical® or Karo® syrup).

If/when frequent feedings prove inadequate, corticosteroids such as prednisone or dexamethasone can be used to assist in raising blood sugar. Ideally dosing is kept as small as necessary so as to avoid side effects such as excessive water consumption and urination and immune suppression.

Diazoxide is a more specialized medication that promotes blood sugar elevation through a number of mechanisms including suppression of insulin secretions. Upset stomach is the most common side effect of this medication and can be palliated by giving the medication with food. It also causes sodium retention and should not be used in heart failure patients. Concurrent liver disease may exacerbate side effects.

Other medications such as somatostatin analogs have not been as reliable in achieving results.

(original graphic by

(original graphic by


Since insulinoma is a cancer, drugs of chemotherapy can be useful in suppressing tumor spread. Such medications are commonly used after surgery has removed the bulk of the tumor or when there is evidence that the tumor has spread. One would not consider such aggressive therapy, though unless a biopsy has confirmed the tumor.


This drug targets beta cells of the pancreas specifically. To avoid inducing kidney failure, it must be given with aggressive intravenous fluids thus hospitalization is required for its periodic use.

Other medications that have been used or are emerging include toceranib, doxorubicin, and alloxan. For the most up to date recommendations on chemotherapy it is necessary to see a veterinary oncologist.




Page posted: 11/19/10
Page last updated: 9/9/2017